RETRACTED: Study on the Role and Mechanism of LncRNA ZFasL in Renal Carcinoma (Retracted Article)

被引:0
作者
Shi, Hongbin [1 ]
Zhu, Hengyu [2 ]
Zhang, Chao [1 ]
Zhou, Xiaojie [2 ]
Ma, Wenzhuo [2 ]
Xu, Haoran [2 ]
Yang, Xiaobo [1 ]
机构
[1] Gen Hosp Ningxia Med Univ, Urol Dept, Yinchuan 750004, Ningxia, Peoples R China
[2] Ningxia Med Univ, Yinchuan 750004, Ningxia, Peoples R China
关键词
CANCER;
D O I
10.1155/2022/9986549
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background. Renal carcinoma is the 7th most common cancer in the world, with the 7th and 6th highest incidence and mortality rates worldwide. Although great progress has been made in the diagnosis and treatment of renal carcinoma, its prognosis is still unsatisfactory. It is important to study the molecular mechanisms of renal carcinoma occurrence and development and to find potential therapeutic targets. Objective. The main objective is to investigate the effects of long noncoding RNA (lncRNA) ZFAS1 (lncZFAS1) on the proliferation, apoptosis, and migration of renal carcinoma cells and to preliminarily explore its mechanism. Methods. A qRT-PCR method was used to detect the expression of lncZFAS1 in renal carcinoma tissues and renal carcinoma cells. After shRNA interference with lncZFAS1 expression, the effects of lncZFAS1 on cell proliferation, apoptosis, migration, and invasion were detected by CCK-8 method, flow cytometry, scratch test, and Transwell assay. The effect of the knockdown of lncZFAS1 on the growth of transplanted tumors was examined. The expression of lncZFAS1 in renal carcinoma tissues and renal carcinoma cells was significantly higher than that in paracancerous tissues and normal esophageal epithelial cells. Knockdown of lncZFAS1 significantly inhibited the proliferation, migration, and invasive ability of renal carcinoma cells; upregulated miR-150-5P expression and downregulated HMGA2 expression in renal carcinoma cells; and significantly inhibited the growth of transplanted tumors in nude mice. Conclusion. Upregulation of miR-150-5P expression was detected after knockdown of lncZFAS1 in renal carcinoma cells, while both mRNA and protein expression levels of HMGA2 were decreased. lncZFAS1 can promote the proliferation and migration of renal carcinoma cells, and the mechanism may be related to the regulation of the miR-150-5P/HMGA2 molecular axis.
引用
收藏
页数:10
相关论文
共 18 条
  • [1] Cui W, 2019, GEN PHYSIOL BIOPHYS, V38, P485, DOI [10.4149/gpb_2019037, 10.4149/gpb2019037]
  • [2] The Long Noncoding RNA ZFAS1 Potentiates the Development of Hepatocellular Carcinoma via the microRNA-624/MDK/ERK/JNK/P38 Signaling Pathway
    Duan, Rui
    Li, Caiyan
    Wang, Fan
    Han, Fei
    Zhu, Ling
    [J]. ONCOTARGETS AND THERAPY, 2020, 13 : 4431 - 4444
  • [3] A Systematic Review of the Efficacy and Safety Experience Reported for Sorafenib in Advanced Renal Cell Carcinoma (RCC) in the Post-Approval Setting
    Fishman, Mayer N.
    Tomshine, Jin
    Fulp, William J.
    Foreman, Pamela K.
    [J]. PLOS ONE, 2015, 10 (04):
  • [4] Fbxo21 regulates the epithelial-to-mesenchymal transition through ubiquitination of Nr2f2 in gastric cancer
    Jiang, Yannan
    Liu, Xinyu
    Shen, Renbin
    Gu, Xinhua
    Qian, Weifeng
    [J]. JOURNAL OF CANCER, 2021, 12 (05): : 1421 - 1430
  • [5] Regulation of lncRNA and Its Role in Cancer Metastasis
    Li, Juan
    Meng, Hui
    Bai, Yun
    Wang, Kai
    [J]. ONCOLOGY RESEARCH, 2016, 23 (05) : 205 - 217
  • [6] LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3
    Sharma, Uttam
    Barwal, Tushar Singh
    Khandelwal, Akanksha
    Malhotra, Akshay
    Rana, Manjit Kaur
    Rana, Amrit Pal Singh
    Imyanitov, Evgeny N.
    Vasquez, Karen M.
    Jain, Aklank
    [J]. BIOCHIMIE, 2021, 182 : 99 - 107
  • [7] Meta-analysis of the prognostic value of lncRNA ZFAS1 in patients with solid tumors
    Song, Wei
    Tian, Chuan
    Zhang, Run-Jin
    Zou, Shu-Bing
    Wang, Kai
    [J]. ONCOTARGET, 2017, 8 (52) : 90301 - 90307
  • [8] LncRNA FOXD2-AS1 as a competitive endogenous RNA against miR-150-5p reverses resistance to sorafenib in hepatocellular carcinoma
    Sui, Chengjun
    Dong, Zhitao
    Yang, Cheng
    Zhang, Minfeng
    Dai, Binghua
    Geng, Li
    Lu, Jiongjiong
    Yang, Jiamei
    Xu, Minhui
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (09) : 6024 - 6033
  • [9] Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
    Sung, Hyuna
    Ferlay, Jacques
    Siegel, Rebecca L.
    Laversanne, Mathieu
    Soerjomataram, Isabelle
    Jemal, Ahmedin
    Bray, Freddie
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2021, 71 (03) : 209 - 249
  • [10] MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma
    Takashima, Yasuo
    Kawaguchi, Atsushi
    Iwadate, Yasuo
    Hondoh, Hiroaki
    Fukai, Junya
    Kajiwara, Koji
    Hayano, Azusa
    Yamanaka, Ryuya
    [J]. PLOS ONE, 2019, 14 (01):